India’s daily COVID-19 cases retreated from record levels on Tuesday, but stayed above the 200,000 mark for a sixth straight day, with cases increasing by 259,170 over the last 24 hours.
Deaths from COVID-19 rose by a record 1,761 to reach a total of 180,530, health ministry data showed.
Meanwhile, India will waive its 10% customs duty on imported COVID-19 vaccines, a senior government official told Reuters on Monday, as it tries to boost supplies to counter a dramatic surge in coronavirus cases.
Imports of Russia’s Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer (PFE.N), Moderna (MRNA.O) and Johnson and Johnson (JNJ.N) to sell their products to India.
The official, who declined to be named, also said the government was considering allowing private entities to import approved vaccines for sale on the open market without government intervention. They could also be given the freedom to set pricing, he added.
The Indian government currently regulates the sale and purchase of all COVID-19 shots in the country.
A finance ministry spokesman did not immediately respond to an email seeking comment outside business hours.
Other South Asian countries, including Nepal and Pakistan, as well as Latin American nations such as Argentina and Brazil levy vaccine import tariffs ranging between 10% and 20%.
The government has now decided to open vaccinations for all adults from May 1.